All Stocks/Healthcare/TECH

BIO-TECHNE Corp

TECH
HealthcareBiotechnology Website
Price ChartPowered by TradingView
Ask about TECHAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Maverick Capital
Lee Ainslie
3.85M$226.47MNEW
Citadel
Ken Griffin
984K$57.89MNEW
Marshall Wace18K$1.08MNEW
About BIO-TECHNE Corp

Bio-Techne Corporation is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics serving the research, diagnostic, and bioprocessing markets worldwide. The company operates through two primary segments: protein sciences, which develops biological reagents including cytokines, growth factors, antibodies, and cell selection technologies; and diagnostics and spatial biology, which provides diagnostic reagents, molecular diagnostics, and spatial biology products. Bio-Techne maintains an extensive catalog of over 500,000 products, with approximately 95% manufactured in-house. Its portfolio includes flagship brands such as R&D Systems, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Asuragen, and Tocris Bioscience, serving academic research institutions, pharmaceutical and biotechnology companies, clinical diagnostic laboratories, and government agencies. Headquartered in Minneapolis, Minnesota, the company operates manufacturing facilities, research centers, and customer support offices across North America, Europe, and Asia-Pacific, generating significant revenue from the United States while maintaining a strong international presence. Bio-Techne's reputation for high-quality proteomic reagents and instruments enables it to maintain strong margins and cash flow while supporting scientific discovery and clinical breakthroughs.

CEO
Mr. Kim Kelderman
Employees
3,100
Quick Facts
Exchange
SectorHealthcare
IndustryBiotechnology
Market Cap
Key Dates

Earnings calendar coming soon. Subscribe to get notified when TECH reports next.

Get earnings alerts →